COCRYSTAL PHARMA, INC. Employee Stock Ownership Plan (ESOP), Compensation Expense
COCRYSTAL PHARMA, INC. (COCP) reported Employee Stock Ownership Plan (ESOP), Compensation Expense of $254.00 thousand for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense · last filed 2016-11-09
- COCRYSTAL PHARMA, INC. employee stock ownership plan (esop), compensation expense for the quarter ending 2016-09-30 was $254.00K, a 65.58% decline year-over-year.
- COCRYSTAL PHARMA, INC. employee stock ownership plan (esop), compensation expense for the quarter ending 2016-06-30 was $719.00K, a 40.97% decline year-over-year.
- COCRYSTAL PHARMA, INC. employee stock ownership plan (esop), compensation expense for the quarter ending 2016-03-31 was $719.00K, a 673.12% increase year-over-year.
- COCRYSTAL PHARMA, INC. employee stock ownership plan (esop), compensation expense for the quarter ending 2015-09-30 was $738.00K, a 14660.00% increase year-over-year.
- COCRYSTAL PHARMA, INC. employee stock ownership plan (esop), compensation expense for fiscal 2014 was $37.58K, a 32.27% decline from fiscal 2013.
- COCRYSTAL PHARMA, INC. employee stock ownership plan (esop), compensation expense for fiscal 2013 was $55.48K.
| Period end | Employee Stock Ownership Plan (ESOP), Compensation Expense 3 month | Employee Stock Ownership Plan (ESOP), Compensation Expense 6 month | Employee Stock Ownership Plan (ESOP), Compensation Expense 6 month as first filed | Employee Stock Ownership Plan (ESOP), Compensation Expense 9 month | Employee Stock Ownership Plan (ESOP), Compensation Expense 12 month |
|---|---|---|---|---|---|
| 2016-09-30 | $254.00K 10-Q · filed 2016-11-09 | $973.00K derived: sum of 2 quarters · filed 2016-11-09 | $1.69M 10-Q · filed 2016-11-09 | ||
| 2016-06-30 | $719.00K 10-Q · filed 2016-08-09 | $1.44M 10-Q · filed 2016-08-09 | |||
| 2016-03-31 | $719.00K 10-Q · filed 2016-05-10 | ||||
| 2015-09-30 | $738.00K 10-Q · filed 2016-11-09 | $1.96M derived: sum of 2 quarters · filed 2016-11-09 | $2.05M 10-Q · filed 2015-11-16 | $2.06M derived: sum of 4 quarters · filed 2016-11-09 | |
| 2015-06-30 | $1.22M 10-Q · filed 2016-08-09 | $1.31M 10-Q · filed 2016-08-09 | $9.00K 10-Q · filed 2015-08-14 | $1.32M derived: sum of 3 quarters · filed 2016-08-09 | $1.33M derived: sum of 4 quarters · filed 2016-08-09 |
| 2015-03-31 | $93.00K 10-Q · filed 2016-05-10 | $105.58K derived: sum of 2 quarters · filed 2016-05-10 | $110.58K derived: sum of 3 quarters · filed 2016-05-10 | $1.42M derived: sum of 4 quarters · filed 2016-05-10 | |
| 2014-12-31 | $12.58K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | $17.58K derived: sum of 2 quarters · filed 2015-11-16 | $1.33M derived: sum of 3 quarters · filed 2015-11-16 | $37.58K 10-K · filed 2015-03-31 | |
| 2014-09-30 | $5.00K 10-Q · filed 2015-11-16 | $1.32M derived: sum of 2 quarters · filed 2015-11-16 | $25.00K 10-Q · filed 2015-11-16 | ||
| 2014-06-30 | $1.31M 10-Q · filed 2015-08-14 | $20.00K 10-Q · filed 2015-08-14 | |||
| 2014-03-31 | $11.00K 10-Q · filed 2015-05-14 | ||||
| 2013-12-31 | $55.48K 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |